Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy
- 20 December 2017
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 33 (7) , 1389-1396
Abstract
Background and Aim: The aim of this study is to investigate the impact of hepatitis B virus (HBV) S gene integration on serum hepatitis B surface antigen (HBsAg) levels in chronic hepatitis B with long‐term nucleos(t)ide analogue (NUC) therapy.Methods: Chronic hepatitis B patients who performed liver biopsy at baseline and treated with long‐term NUC therapy were recruited. The integration of HBV S gene in baseline liver biopsy specimen was detected by Alu polymerase chain reaction method. Serum HBsAg levels were measured at baseline and the second year and the fourth year after NUC therapy by Roche reagent, respectively. Serum HBsAg levels between HBV S gene integrated group and nonintegrated group were compared and analyzed.Results: Seventy patients were eligible for this study. Among them, 11 (15.7%) were found to have HBV S gene integration in their baseline liver biopsy specimens. Similar significant decrease of HBsAg levels was found in both integrated and nonintegrated groups (2.63vs2.65 log IU/mL,P = 0.478) after the first 2 years of NUC therapy. Thereafter, the decrease of HBsAg level from 2 to 4 years after therapy was largely unchanged in integrated group as compared with that of nonintegrated group (0.1vs2.53 log IU/mL,P = 0.002), with statistical difference.Conclusions: Serum HBsAg could be originated from the expression of the integrated HBV S gene in patients with S gene integration, which implicated the limitations when regarding HBsAg as a surrogate biomarker of covalently closed circular DNA activity and as an indicator of safe NUC discontinuation.Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2014GXNSFDA118023)
- Ministry of Health of the People's Republic of China (2017ZX10202201)
This publication has 34 references indexed in Scilit:
- Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomasBMC Medical Genomics, 2014
- Predictors of relapse in chronic hepatitis B after discontinuation of anti‐viral therapyAlimentary Pharmacology & Therapeutics, 2011
- Chronic hepatitis B in Asia—new insights from the past decadeJournal of Gastroenterology and Hepatology, 2011
- A Longitudinal Study on the Natural History of Serum Hepatitis B Surface Antigen Changes in Chronic Hepatitis BHepatology, 2010
- Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus MarkersHepatology, 2010
- Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patientsJournal of Hepatology, 2008
- Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapyJournal of Viral Hepatitis, 2006
- Hepatocellular Carcinoma and Hepatitis B VirusSeminars in Liver Disease, 2006
- A Systematic Review of the Quality of Liver Biopsy SpecimensAmerican Journal of Clinical Pathology, 2006
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis BHepatology, 2002